Literature DB >> 11723375

Clinical trials in neuro-oncology.

T Batchelor1, K Stanley, J Andersen.   

Abstract

Clinical trials are prospective scientific studies involving human participants and form the basis for identifying new treatments for diseases like brain tumors. A clinical trial should be designed to provide definitive results for a study question. Therefore, investigators should understand the principles underlying the design, execution and analysis of clinical trials. In addition to the application of basic principles germane to the design of all clinical trials, studies in neuro-oncology also involve unique challenges in case definition, selection of endpoints and definition of response. This review begins with enumeration of the basic principles of clinical trial design including reduction of bias and variability, and concludes with a review of study design factors of particular relevance for neuro-oncology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723375     DOI: 10.1097/00019052-200112000-00003

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  4 in total

Review 1.  Brain tumor imaging in clinical trials.

Authors:  J W Henson; S Ulmer; G J Harris
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

2.  The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.

Authors:  Karla V Ballman; Jan C Buckner; Paul D Brown; Caterina Giannini; Patrick J Flynn; Betsy R LaPlant; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2006-11-15       Impact factor: 12.300

3.  Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme.

Authors:  Nicholas Butowski; Kathleen R Lamborn; Mitchel S Berger; Michael D Prados; Susan M Chang
Journal:  J Neurooncol       Date:  2007-04-25       Impact factor: 4.130

4.  Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges.

Authors:  Gazanfar Rahmathulla; Elizabeth J Hovey; Neda Hashemi-Sadraei; Manmeet S Ahluwalia
Journal:  Onco Targets Ther       Date:  2013-04-15       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.